Banco Bilbao Vizcaya Argentaria’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,557
| Closed | -$224K | – | 738 |
|
|
2024
Q1 | $224K | Buy |
+2,557
| New | +$224K | ﹤0.01% | 745 |
|
|
2023
Q4 | – | Sell |
-2,740
| Closed | -$244K | – | 733 |
|
|
2023
Q3 | $244K | Buy |
+2,740
| New | +$244K | ﹤0.01% | 693 |
|
|
2022
Q4 | – | Sell |
-2,747
| Closed | -$236K | – | 714 |
|
|
2022
Q3 | $236K | Sell |
2,747
-1,170
| -30% | -$101K | ﹤0.01% | 686 |
|
|
2022
Q2 | $325K | Buy |
+3,917
| New | +$325K | ﹤0.01% | 622 |
|
|
2022
Q1 | – | Sell |
-3,322
| Closed | -$296K | – | 716 |
|
|
2021
Q4 | $296K | Sell |
3,322
-74,512
| -96% | -$6.64M | ﹤0.01% | 736 |
|
|
2021
Q3 | $6.03M | Sell |
77,834
-119,174
| -60% | -$9.23M | 0.09% | 187 |
|
|
2021
Q2 | $16.4M | Buy |
197,008
+30,294
| +18% | +$2.52M | 0.29% | 63 |
|
|
2021
Q1 | $12.6M | Buy |
166,714
+58,662
| +54% | +$4.44M | 0.25% | 81 |
|
|
2020
Q4 | $9.48M | Sell |
108,052
-18,955
| -15% | -$1.66M | 0.22% | 88 |
|
|
2020
Q3 | $9.66M | Buy |
127,007
+105,088
| +479% | +$7.99M | 0.28% | 60 |
|
|
2020
Q2 | $2.7M | Buy |
21,919
+18,079
| +471% | +$2.23M | 0.09% | 194 |
|
|
2020
Q1 | $324K | Buy |
+3,840
| New | +$324K | 0.01% | 561 |
|